Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts

Preclinical studies have demonstrated that propranolol inhibits several pathways involved in breast cancer progression and metastasis. We investigated whether breast cancer patients who used propranolol, or other non-selective beta-blockers, had reduced breast cancer-specific or all-cause mortality...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research : BCR 2016-12, Vol.18 (1), p.119-119, Article 119
Hauptverfasser:	Cardwell, Chris R, Pottegård, Anton, Vaes, Evelien, Garmo, Hans, Murray, Liam J, Brown, Chris, Vissers, Pauline A J, O'Rorke, Michael, Visvanathan, Kala, Cronin-Fenton, Deirdre, De Schutter, Harlinde, Lambe, Mats, Powe, Des G, van Herk-Sukel, Myrthe P P, Gavin, Anna, Friis, Søren, Sharp, Linda, Bennett, Kathleen
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Angiogenesis Inhibitors - therapeutic use Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - mortality Care and treatment Cohort Studies Development and progression Europe Female Health aspects Humans Proportional Hazards Models Propranolol - therapeutic use Propranolol hydrochloride Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!